Galderma Group AG (XSWX:GALD) FCF Yield % : -0.14 (As of Mar. 04, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Galderma Group AG's Trailing 12-Month Free Cash Flow is CHF-38 Mil, and Market Cap is CHF26,764 Mil. Therefore, Galderma Group AG's FCF Yield % for today is -0.14%.

The historical rank and industry rank for Galderma Group AG's FCF Yield % or its related term are showing as below:

XSWX:GALD' s FCF Yield % Range Over the Past 10 Years
Min: -0.2 Med: 0 Max: 0
Current: -0.14

XSWX:GALD's FCF Yield % is ranked worse than
52.86% of 1033 companies
in the Drug Manufacturers industry
Industry Median: 0.16 vs XSWX:GALD: -0.14

Galderma Group AG's FCF Margin % for the quarter that ended in Jun. 2024 was -1.90%.

Galderma Group AG FCF Yield % Historical Data

The historical data trend for Galderma Group AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG FCF Yield % Chart

Galderma Group AG Annual Data

Trend

FCF Yield %

Galderma Group AG Semi-Annual Data
	Jun23	Jun24
FCF Yield %	-	-0.43

Competitive Comparison of Galderma Group AG's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's FCF Yield % falls into.

Galderma Group AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Galderma Group AG's FCF Yield % for the fiscal year that ended in . 20 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=		/
	=	N/A%

Galderma Group AG's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-37.54	*	2	/	17570.38136
	=	-0.43%

Galderma Group AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Galderma Group AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

GALDY:USA GALDz:UK PY30:Germany

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines